bpc-157 regulatory status current fda approval 2026 NBC News fda restrictions on bpc-157 compounding

B12 sources include: Animal products like eggs, fish, milk, and meat

In the FY 2022 IPPS/LTCH PPS final rule we indicated that we agreed with commenters that we needed to further consider the questions raised by commenters regarding the ability of the payer-specific charges negotiated between hospitals and MAOs to represent market-based pricing given the relationship between Medicare FFS and MAO rates

BPC-157 is not FDA-approved for any human therapeutic indication

Treatment did not adversely affect kidney weight or overall organ architecture, indicating selective targeting without compromising healthy renal tissue

That's the map, but the consult is where it actually gets decided, because two people with the same goal can have very different labs

Total $200-$740 monthly for comprehensive protocol